Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Analysis of the PD-1/PD-L1 Axis Points to Association of Unfavorable Recurrent Mutations with PD-L1 Expression in AML

Malgorzata Zajac, PhD, Joanna Zaleska, Anna Dolnik, PhD, Anna Siwiec, PhD, Olga Jankowska-Lecka, PhD, Radoslaw Mlak, PhD, Marzanna Ciesielka, PhD, Tomasz Gromek, MD PhD, Bozena Sokolowska, MD PhD, Norbert Grzasko, MD PhD, Maria Soroka-Wojtaszko, MD PhD, Aneta Szudy-Szczyrek, MD, Maria Majdan, MD, Marek Hus, MD PhD, Lars Bullinger, MD, Krzysztof Giannopoulos, MD PhD

Blood (2016) 128 (22): 1685.

https://doi.org/10.1182/blood.V128.22.1685.1685

Published: 2016

Journal Articles

Clinical and Biological Role of Accumulation of the NPM-1 Splice Variant R2 in AML, MDS and sAML

Grazyna Stasiak, PhD, Malgorzata Zajac, PhD, Joanna Zaleska, Michal Kielbus, PhD, Jakub Czapinski, Andrzej Stepulak, MD PhD, Olga Jankowska-Lecka, PhD, Tomasz Gromek, MD PhD, Norbert Grzasko, MD PhD, Maria Soroka-Wojtaszko, MD PhD, Aneta Szudy-Szczyrek, MD, Bozena Sokolowska, MD PhD, Marek Hus, MD PhD, Lars Bullinger, MD PhD, Krzysztof Giannopoulos, MD PhD

Blood (2016) 128 (22): 2878.

https://doi.org/10.1182/blood.V128.22.2878.2878

Published: 2016

Journal Articles

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Blood (2016) 128 (22): 213.

https://doi.org/10.1182/blood.V128.22.213.213

Published: 2016

Journal Articles

Accumulation of the NPM-1 Splice Variant R2 Accompanies AML Development

Krzysztof Giannopoulos, MD PhD, Malgorzata Zajac, PhD, Olga Jankowska-Lecka, PhD, Joanna Zaleska, Joanna Purkot, Tomasz Gromek, MD, Maria Soroka-Wojtaszko, MD PhD, Aneta Szudy-Szczyrek, MD, Marek Hus, MD PhD, Lars Bullinger, MD

Blood (2015) 126 (23): 2590.

https://doi.org/10.1182/blood.V126.23.2590.2590

Published: 2015

Journal Articles

Purine Analogues Based Induction Regimen Followed By Allo-HSCT Is An Effective Treatment Modality Of Philadelphia Chromosome-Positive Acute Myeloid Leukemia-Retrospective Analysis Of Polish Adult Leukemia Group (PALG)

Agnieszka Wierzbowska, MD, PhD, Anna Szmigielska-Kaplon, MD, PhD, Agnieszka Pluta, MD, PhD, Ewa Wawrzyniak, PhD, Sebastian Grosicki, MD, Grzegorz Helbig, MD, PhD, Wanda Knopinska-Posluszny, MD, PhD, Tomasz Gromek, MD, PhD, Ilona Seferynska, MD, PhD, Ewa Lech-Maranda, Jerzy Holowiecki, Tadeusz Robak

Blood (2013) 122 (21): 1461.

https://doi.org/10.1182/blood.V122.21.1461.1461

Published: 2013

Journal Articles

JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Bozena Sokolowska, MD, PhD, Aleksandra Nowaczynska, PhD, Ksenia Bykowska, PhD, Sylwia Chocholowska, PhD, Katarzyna Wejksza, PhD, Adam Walter-Cronack, MD, PhD, Martyna Kandefer-Szerszen, PhD, Tomasz Gromek, MD, PhD, M. Anna Kowalska, PhD, Anna Dmoszynska, MD, PhD

Blood (2008) 112 (11): 4542.

https://doi.org/10.1182/blood.V112.11.4542.4542

Published: 2008

Journal Articles

Fibrinolytic Activity in Patients with Essential Thrombocythemia.

Bozena Sokolowska, MD, PhD, Aleksandra Nowaczynska, MSc, Katarzyna Wejksza, MSc, Adam Walter-Croneck, MD, Martyna Kandefer-Szerszen, PhD, Tomasz Gromek, MD, M. Anna Kowalska, PhD, Anna Dmoszynska, MD, PhD

Blood (2007) 110 (11): 3223.

https://doi.org/10.1182/blood.V110.11.3223.3223

Published: 2007

NARROW

Analysis of the PD-1/PD-L1 Axis Points to Association of Unfavorable Recurrent Mutations with PD-L1 Expression in AML

Clinical and Biological Role of Accumulation of the NPM-1 Splice Variant R2 in AML, MDS and sAML

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Accumulation of the NPM-1 Splice Variant R2 Accompanies AML Development

Purine Analogues Based Induction Regimen Followed By Allo-HSCT Is An Effective Treatment Modality Of Philadelphia Chromosome-Positive Acute Myeloid Leukemia-Retrospective Analysis Of Polish Adult Leukemia Group (PALG)

JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Fibrinolytic Activity in Patients with Essential Thrombocythemia.

Email alerts

ASH Publications

American Society of Hematology

Analysis of the PD-1/PD-L1 Axis Points to Association of Unfavorable Recurrent Mutations with PD-L1 Expression in AML

Clinical and Biological Role of Accumulation of the NPM-1 Splice Variant R2 in AML, MDS and sAML

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Accumulation of the NPM-1 Splice Variant R2 Accompanies AML Development

Purine Analogues Based Induction Regimen Followed By Allo-HSCT Is An Effective Treatment Modality Of Philadelphia Chromosome-Positive Acute Myeloid Leukemia-Retrospective Analysis Of Polish Adult Leukemia Group (PALG)

JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Fibrinolytic Activity in Patients with Essential Thrombocythemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only